• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟卡尼治疗对儿茶酚胺能多形性室性心动过速中不适当电击和心律失常的影响。

Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.

作者信息

Jacquemart Caroline, Ould Abderrahmane Fazia, Massin Martial M

机构信息

Division of Pediatric Cardiology, Queen Fabiola Children's University Hospital, HUDERF, Free University of Brussels, ULB, Brussels, Belgium.

出版信息

J Electrocardiol. 2012 Nov-Dec;45(6):736-8. doi: 10.1016/j.jelectrocard.2012.05.002. Epub 2012 Jun 4.

DOI:10.1016/j.jelectrocard.2012.05.002
PMID:22672791
Abstract

We report the case of a child with catecholaminergic polymorphic ventricular tachycardia, who had inappropriate electric shocks by an implantable cardioverter defibrillator and from recurrence of arrhythmias despite an appropriate β-blocking treatment. An additional treatment by flecainide completely suppressed inappropriate shocks due to sinusal tachycardia and ventricular tachyarrhythmias. We briefly discuss the potentially interesting effect of flecainide in this specific arrhythmia.

摘要

我们报告了一例儿茶酚胺能多形性室性心动过速患儿的病例,该患儿植入式心脏复律除颤器出现不适当电击,尽管接受了适当的β受体阻滞剂治疗,但心律失常仍复发。氟卡尼的额外治疗完全抑制了由窦性心动过速和室性快速心律失常引起的不适当电击。我们简要讨论了氟卡尼在这种特定心律失常中可能具有的有趣作用。

相似文献

1
Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.氟卡尼治疗对儿茶酚胺能多形性室性心动过速中不适当电击和心律失常的影响。
J Electrocardiol. 2012 Nov-Dec;45(6):736-8. doi: 10.1016/j.jelectrocard.2012.05.002. Epub 2012 Jun 4.
2
Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.氟卡尼可抑制儿茶酚胺能性多形性室性心动过速中除颤器诱发的风暴发作。
Pacing Clin Electrophysiol. 2012 Jul;35(7):794-7. doi: 10.1111/j.1540-8159.2012.03421.x. Epub 2012 May 3.
3
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.氟卡尼治疗可抑制 CASQ2 相关儿茶酚胺敏感性多形性室性心动过速患者运动诱发的室性心律失常。
Heart Rhythm. 2013 Nov;10(11):1671-5. doi: 10.1016/j.hrthm.2013.08.011. Epub 2013 Aug 13.
4
Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.儿茶酚胺多形性室性心动过速患者中埋藏式心脏复律除颤器的疗效:成功取决于基质。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):579-87. doi: 10.1161/CIRCEP.113.000170. Epub 2013 May 11.
5
Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.氟卡尼成功治疗儿茶酚胺多形性室性心动过速 1 例报告并文献复习
Europace. 2011 Jun;13(6):897-901. doi: 10.1093/europace/euq517. Epub 2011 Feb 2.
6
Treatment for patients with catecholaminergic polymorphic ventricular tachycardia: are we in need of randomized trials?儿茶酚胺能多形性室性心动过速患者的治疗:我们是否需要进行随机试验?
J Electrocardiol. 2012 Nov-Dec;45(6):739-40. doi: 10.1016/j.jelectrocard.2012.06.027. Epub 2012 Jul 25.
7
Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.将植入式心脏复律除颤器升级为心脏再同步治疗除颤器设备后出现多次电击。
Cardiol J. 2009;16(5):473-6.
8
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.氟卡尼治疗可减少儿茶酚胺多形性室性心动过速患者运动诱发的室性心律失常。
J Am Coll Cardiol. 2011 May 31;57(22):2244-54. doi: 10.1016/j.jacc.2011.01.026.
9
Catecholaminergic polymorphic ventricular tachycardia: important messages from case reports.儿茶酚胺能多形性室性心动过速:病例报告的重要信息
Europace. 2011 Jan;13(1):11-3. doi: 10.1093/europace/euq330. Epub 2010 Sep 17.
10
Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.伊伐布雷定预防植入式心脏复律除颤器患者窦性心动过速引起的不适当电击。
Europace. 2013 Mar;15(3):362-5. doi: 10.1093/europace/eus343. Epub 2012 Nov 1.

引用本文的文献

1
Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia.儿茶酚胺能多形性室性心律失常患者经静脉植入式心律转复除颤器与皮下植入式心律转复除颤器并发症的汇总分析。
J Pers Med. 2022 Mar 28;12(4):536. doi: 10.3390/jpm12040536.
2
Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload.氟卡尼在儿茶酚胺能多形性室性心动过速中的疗效与突变无关,但会因钙超载而降低。
Front Physiol. 2019 Aug 13;10:992. doi: 10.3389/fphys.2019.00992. eCollection 2019.
3
Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.
氟卡尼的多种作用靶点:对心脏心律失常发生机制的影响。
Br J Pharmacol. 2018 Apr;175(8):1260-1278. doi: 10.1111/bph.13807. Epub 2017 May 12.
4
The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.氟卡尼在儿茶酚胺能多形性室性心动过速治疗中的作用
Arrhythm Electrophysiol Rev. 2016 May;5(1):45-9. doi: 10.15420/aer.2016.3.3.
5
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.儿童儿茶酚胺能多形性室性心动过速:来自一项国际多中心注册研究的治疗策略与结果分析
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):633-42. doi: 10.1161/CIRCEP.114.002217. Epub 2015 Feb 24.